Biological Evolution in a Homozygous Adult with Sickle Cell Disease on Hydroxyurea: A Case Report (original) (raw)

Sickle Cell Disease

Martin Meremikwu

American Journal of Preventive Medicine, 2011

View PDFchevron_right

Sickle-cell trait: novel clinical significance

Nigel Key

2010

View PDFchevron_right

Evidence review of hydroxyurea for the prevention of sickle cell complications in low-income countries

Jamlick Karumbi

Archives of Disease in Childhood, 2013

View PDFchevron_right

Fixed Low-Dose Hydroxyurea for the Treatment of Adults with Sickle Cell Anemia in Nigeria

Lewis Hsu

American journal of hematology, 2018

View PDFchevron_right

Sickle Cell Crisis

Mary Wilby

Adult-Gerontology Acute Care Practice Guidelines, 2019

View PDFchevron_right

Differences in the clinical and genotypic presentation of sickle cell disease around the world

Robert Molokie

Paediatric Respiratory Reviews, 2014

View PDFchevron_right

Impact of Genetic Variations on Thromboembolic Risk in Saudis with Sickle Cell Disease

Hussain Al Saeed

Genes, 2023

View PDFchevron_right

Cytotoxic and genotoxic monitoring of sickle cell anaemia patients treated with hydroxyurea

Regiane Santos

Clinical and Experimental Medicine, 2006

View PDFchevron_right

Sickle Cell Disease (SCD)

Ahmad Darwish

Inherited Hemoglobin Disorders, 2015

View PDFchevron_right

Sickle-cell disease in a British urban community

Betty Kirkwood

BMJ, 1981

View PDFchevron_right

Genitourinary manifestations of sickle cell disease

Matthew Simmons

Cleveland Clinic Journal of Medicine, 2015

View PDFchevron_right

- Knowledge and Awareness Assessment towards Sickle Cell Anemia

Abeer Mohammad

View PDFchevron_right

HCV In Sickle Cell Disease

Mohamed Hassan

Journal of the national …, 2003

View PDFchevron_right

Erythroid adhesion molecules in sickle cell disease: Effect of hydroxyurea

Jacques Elion

Transfusion Clinique et Biologique, 2008

View PDFchevron_right

Systematic Review: Hydroxyurea for the Treatment of Adults with Sickle Cell Disease

Renee Wilson

Annals of Internal Medicine, 2008

View PDFchevron_right

Perspective: A novel prognostic for sickle cell disease

Amein Al-Ali

Saudi Journal of Medicine and Medical Sciences, 2018

View PDFchevron_right

Retrospection of the effect of hydroxyurea treatment in patients with sickle cell disease

H. Verma

View PDFchevron_right

Real-life experience with hydroxyurea in sickle cell disease: A multicenter study in a cohort of patients with heterogeneous descent

Gian Forni

Blood cells, molecules & diseases, 2017

View PDFchevron_right

Sickle Cell Disease in Childhood in Madina

amirullah mokhles

Annals of Saudi Medicine, 1998

View PDFchevron_right

COVID-19 Infection and Homozygous SS Sickle Cell Disease in Children: About Two Cases in Ziguinchor/Senegal

Ousmane Ndiaye

Open Journal of Pediatrics, 2020

View PDFchevron_right

Effects of the Sickle Cell (S) Gene on Serum Protein Profile

MATTHEW E ADU

2012

View PDFchevron_right

The influence of hydroxyurea on oxidative stress in sickle cell anemia

Milton Ruiz

Revista Brasileira de Hematologia e Hemoterapia, 2012

View PDFchevron_right

Determination of birth prevalence of sickle cell disease using point of care test HemotypeSC™ at Rundu Hospital, Namibia

Patience Kuona

BMC pediatrics, 2024

View PDFchevron_right

Current sickle cell disease management practices in Nigeria

Prof. (Mrs) N. O. Akinola

International Health, 2013

View PDFchevron_right

Pharmacy Hydroxyurea Education Materials for Patients with Sickle Cell Disease: An Environmental Scan and Assessment of Accuracy

Mona Azzam

Blood, 2017

View PDFchevron_right

Hydroxyurea in sickle cell disease—A study of clinico-pharmacological efficacy in the Indian haplotype

Anita Nadkarni, Farah Jijina

Blood Cells, Molecules, and Diseases, 2009

View PDFchevron_right

Àgô Sankofa: an overview of the progression of sickle cell disease in Brazil in the past two decades

Altair Lira

Ciência & Saúde Coletiva, 2024

View PDFchevron_right

Improving Outcomes for Patients With Sickle Cell Disease in the United States

Angela Snyder

JAMA Health Forum, 2021

View PDFchevron_right

Sickle Cell Disease in Jhabua and Khargone District: Unveiling Prevalence and Severity

Dr.Siddharth Ojha

International journal of pharmacy and pharmaceutical sciences/International Journal of Pharmacy and Pharmaceutical Sciences, 2024

View PDFchevron_right

Hydroxyurea for the Treatment of Sickle Cell Disease

Arjumand S. Warsy

Acta Haematologica, 1992

View PDFchevron_right

Association Between Sickle Cell Trait With Selected Chronic Medical Conditions in U.S. Service Members

David Niebuhr

Military Medicine, 2018

View PDFchevron_right

An up-date on the prevalence of sickle cell trait in Eastern and Western Uganda

Michael Ocaido

BMC Blood Disorders, 2010

View PDFchevron_right

New Therapies for Sickle Cell Disease

Iheanyi Okpala

Hematology/Oncology Clinics of North America, 2005

View PDFchevron_right

Research letter. The sickle cell gene frequency in Southern Iran

Mahboobeh Yadollahie

Journal of Tropical Pediatrics, 2000

View PDFchevron_right